The North America Cervical Cancer Diagnostics and Therapeutics market has been estimated at USD 1168.20 Million in 2016 and is projected to reach USD 1414.47 Million by 2021, at a CAGR of 3.90% during the forecast period from 2016 to 2021.Cervical cancer was once one of the most common causes of cancer death for American women. But over the last 40 years, the cervical cancer death rate has gone down by more than 50%. The main reason for this change was the increased use of ... Read more
